Literature DB >> 11259949

Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging.

I Ciray1, H Lindman, K G Aström, J Bergh, K H Ahlström.   

Abstract

PURPOSE: To compare T1-weighted spin-echo and fat-suppressed long echo time inversion recovery turbo spin-echo (long TE IR-TSE) MR images in the evaluation of early response of breast cancer bone metastases to chemotherapy.
MATERIAL AND METHODS: Eighteen breast cancer patients with known bone metastases were investigated prospectively by MR, using T1-weighted and long TE IR-TSE sequences on the sternum, spine, pelvis and proximal femora, before and after a median of 6 courses of chemotherapy. Therapeutic response evaluation with MR was based on change in tumor size assessed quantitatively by measuring all focal metastases, and change in pattern and signal intensity (SI) of the metastases, assessed visually. Combined response evaluation based on clinical findings, conventional radiography, and scintigraphy was used as reference.
RESULTS: Progressive disease (2 patients) and no change (4 patients) were assessed equally well on both MR sequences. Long TE IR-TSE demonstrated partial response with higher accuracy than T1-weighted images, 58% (7/12 patients) vs. 17% (2/12 patients). In patients without progression there was an SI increase in or around the metastases in 6 patients on T1-weighted images and in 7 patients on long TE IR-TSE images.
CONCLUSION: The long TE IR-TSE sequence demonstrated early partial response of breast cancer bone metastases to chemotherapy more accurately than the T1-weighted sequence.

Entities:  

Mesh:

Year:  2001        PMID: 11259949     DOI: 10.1080/028418501127346503

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.701


  12 in total

Review 1.  MRI for response assessment in metastatic bone disease.

Authors:  F E Lecouvet; A Larbi; V Pasoglou; P Omoumi; B Tombal; N Michoux; J Malghem; R Lhommel; B C Vande Berg
Journal:  Eur Radiol       Date:  2013-03-01       Impact factor: 5.315

2.  Surgical treatment strategies and outcome in patients with breast cancer metastatic to the spine: a review of 87 patients.

Authors:  Joseph A Shehadi; Daniel M Sciubba; Ian Suk; Dima Suki; Marcos V C Maldaun; Ian E McCutcheon; Remi Nader; Richard Theriault; Laurence D Rhines; Ziya L Gokaslan
Journal:  Eur Spine J       Date:  2007-04-04       Impact factor: 3.134

3.  Follow-up CT and MR findings of osteoblastic spinal metastatic lesions after stereotactic radiotherapy.

Authors:  Yoon Joon Hwang
Journal:  Jpn J Radiol       Date:  2012-04-12       Impact factor: 2.374

4.  Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa).

Authors:  F E Lecouvet; M Simon; B Tombal; J Jamart; B C Vande Berg; P Simoni
Journal:  Eur Radiol       Date:  2010-07-27       Impact factor: 5.315

5.  Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria.

Authors:  V Vassiliou; D Andreopoulos
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

6.  Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease.

Authors:  Daniel M Sciubba; Ziya L Gokaslan; Ian Suk; Dima Suki; Marcos V C Maldaun; Ian E McCutcheon; Remi Nader; Richard Theriault; Laurence D Rhines; Joseph A Shehadi
Journal:  Eur Spine J       Date:  2007-05-08       Impact factor: 3.134

7.  18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer.

Authors:  Joan Duch; David Fuster; Montserrat Muñoz; Pedro Luís Fernández; Pilar Paredes; Montserrat Fontanillas; Flavia Guzmán; Sebastià Rubí; Francisco Juan Lomeña; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-27       Impact factor: 9.236

8.  Comparison of 3T diffusion-weighted MRI and 18F-FDG PET/CT in musculoskeletal tumours: quantitative analysis of apparent diffusion coefficients and standardized uptake values.

Authors:  So-Yeon Lee; Won-Hee Jee; Ie Ryung Yoo; Joon-Yong Jung; Soo-A Im; Yang-Guk Chung; Jin Hyoung Kang
Journal:  Br J Radiol       Date:  2019-07-24       Impact factor: 3.039

9.  Conventional finite element models estimate the strength of metastatic human vertebrae despite alterations of the bone's tissue and structure.

Authors:  Marc A Stadelmann; Denis E Schenk; Ghislain Maquer; Christopher Lenherr; Florian M Buck; Dieter D Bosshardt; Sven Hoppe; Nicolas Theumann; Ron N Alkalay; Philippe K Zysset
Journal:  Bone       Date:  2020-08-20       Impact factor: 4.626

Review 10.  Evaluation of the response to treatment of solid tumours - a consensus statement of the International Cancer Imaging Society.

Authors:  J E Husband; L H Schwartz; J Spencer; L Ollivier; D M King; R Johnson; R Reznek
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.